Clinical Trial Update: Antiinflammatoric and Antioxidative Effect of Melatonin in Human Endotoxaemia [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the anti-inflammatory and antioxidative effects of melatonin in humans with endotoxemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endotoxemia

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Herlev Hospital | Conditions: Human Endotoxaemia | Phase 4 | Status: COMPLETED